{"url":"https://lda.senate.gov/api/v1/filings/f7ca4e75-561c-461b-b1aa-44fbeda0494d/","filing_uuid":"f7ca4e75-561c-461b-b1aa-44fbeda0494d","filing_type":"Q4","filing_type_display":"4th Quarter - Report","filing_year":2021,"filing_period":"fourth_quarter","filing_period_display":"4th Quarter (Oct 1 - Dec 31)","filing_document_url":"https://lda.senate.gov/filings/public/filing/f7ca4e75-561c-461b-b1aa-44fbeda0494d/print/","filing_document_content_type":"text/html","income":"16000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Kathy Lester","dt_posted":"2022-02-09T16:02:53.133000-05:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"601 13th Street, NW","registrant_address_2":"11th Floor","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20005","registrant":{"id":401103249,"url":"https://lda.senate.gov/api/v1/registrants/401103249/","house_registrant_id":null,"name":"LESTER HEALTH LAW PLLC","description":"law firm","address_1":"601 13th Street, NW","address_2":"12th Floor","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20005","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"KATHY LESTER","contact_telephone":"+1 202-534-1773","dt_updated":"2026-06-30T19:34:55.623104-04:00"},"client":{"id":198303,"url":"https://lda.senate.gov/api/v1/clients/198303/","client_id":90,"name":"CARA THERAPEUTICS","general_description":"biotechnology company","client_government_entity":false,"client_self_select":null,"state":"CT","state_display":"Connecticut","country":"US","country_display":"United States of America","ppb_state":"CT","ppb_state_display":"Connecticut","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2018-09-20"},"lobbying_activities":[{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"ESRD prospective payment system CY 2022 proposed rule and guidance; Medicare Advantage Program; Cures 2.0","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":60099,"prefix":null,"prefix_display":null,"first_name":"KATHLEEN","nickname":null,"middle_name":null,"last_name":"LESTER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}